HALAVEN (eribulin mesylate)
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
EISAI INC.
Indication
Liposarcoma
Liposarcoma is a rare malignant soft-tissue sarcoma that originates in adipocytic precursor cells. Read more about Liposarcoma
15 drugs 14 manufacturers
Drugs that treat it
Common Liposarcoma therapies.
YONDELIS (trabectedin)
ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS·LEIOMYOSARCOMA·+1
JANSSEN PRODUCT
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
Baxter Healthcare Company
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
APOTEX CORP
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
GLAND PHARMA LI
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
LONG GROVE PHAR
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
Hikma Pharmaceuticals USA
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
SUN PHARMACEUTI
ERIBULIN MESYLATE
HALOCHONDRIN B ANALOGS, MICROTUBULE INHIBITOR·METASTATIC BREAST CARCINOMA·+1
SANDOZ
Filter & compare in the drug finder →Opens the drug finder with Liposarcoma preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLiposarcoma is a rare malignant soft-tissue sarcoma that originates in adipocytic precursor cells.
It predominantly affects adults, most frequently developing in the deep soft tissues of the retroperitoneum and the extremities, particularly the thigh.
Pathophysiologically and histologically, the disease encompasses distinct subtypes, including well-differentiated, dedifferentiated, myxoid/round cell, and pleomorphic variants, which are defined by variable degrees of lipoblastic differentiation, cytogenetic abnormalities such as *MDM2* and *CDK4* gene amplification or characteristic chromosomal translocations, and clinical behavior that ranges from locally indolent to aggressively metastatic.
Clinically, it typically presents as an enlarging, painless deep-tissue mass that produces compressive symptoms as it expands into adjacent structures.
- cancer.gov
Liposarcoma is a rare malignant soft-tissue sarcoma that originates in adipocytic precursor cells It predominantly affects adults, most frequently developing in the deep soft tissues of the retroperitoneum and the extremities, particularly the thigh Pathophysiologically and histologically, the disease encompasses distinct subtypes, including well-differentiated, dedifferentiated, myxoid/round cell, and pleomorphic variants, which are defined by variable degrees of lipoblastic differentiation, cy...
- childrenshospital.org
Liposarcoma is a rare malignant soft-tissue sarcoma that originates in adipocytic precursor cells It predominantly affects adults, most frequently developing in the deep soft tissues of the retroperitoneum and the extremities, particularly the thigh Pathophysiologically and histologically, the disease encompasses distinct subtypes, including well-differentiated, dedifferentiated, myxoid/round cell, and pleomorphic variants, which are defined by variable degrees of lipoblastic differentiation, cy...
- nih.gov
Pathophysiologically and histologically, the disease encompasses distinct subtypes, including well-differentiated, dedifferentiated, myxoid/round cell, and pleomorphic variants, which are defined by variable degrees of lipoblastic differentiation, cytogenetic abnormalities such as *MDM2* and *CDK4* gene amplification or characteristic chromosomal translocations, and clinical behavior that ranges from locally indolent to aggressively metastatic
Personalize your experience
Follow Liposarcoma and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.